Bioceres Crop Solutions Corp.

Informe acción NasdaqGS:BIOX

Capitalización de mercado: US$743.3m

Salud financiera de hoja de balance de Bioceres Crop Solutions

Salud financiera controles de criterios 3/6

Bioceres Crop Solutions tiene un patrimonio de accionistas total de $335.3M y una deuda total de $223.0M, lo que sitúa su ratio deuda-patrimonio en 66.5%. Sus activos y pasivos totales son $819.5M y $484.3M respectivamente. El BAIT de Bioceres Crop Solutions es de $53.2M, por lo que su ratio de cobertura de intereses es de 2.6. Tiene efectivo e inversiones a corto plazo que ascienden a $41.4M.

Información clave

66.5%

Ratio deuda-patrimonio

US$223.04m

Deuda

Ratio de cobertura de intereses2.6x
EfectivoUS$41.44m
PatrimonioUS$335.26m
Total pasivoUS$484.26m
Activos totalesUS$819.52m

Actualizaciones recientes sobre salud financiera

Recent updates

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($392.0M) de BIOX superan a sus pasivos a corto plazo ($316.8M).

Pasivo a largo plazo: Los activos a corto plazo de BIOX ($392.0M) superan a sus pasivos a largo plazo ($167.5M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de BIOX (54.2%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de BIOX ha pasado de 195.9% a 66.5% en los últimos 5 años.

Cobertura de la deuda: BIOX's debt is not well covered by operating cash flow (13.2%).

Cobertura de intereses: Los pagos de intereses de la deuda de BIOX no están bien cubiertos por el BAIT (2.6x cobertura).


Hoja de balance


Descubre empresas con salud financiera